Malaysia gets first stereotaxy service:
This article was originally published in Clinica
Executive Summary
The private hospital group, Hospital Pantai, has launched a new stereotactic radiosurgery and radiotherapy service at its hospital in Kuala Lumpur, the first of its kind in Malaysia. The service, set up at a cost of RM2 million ($0.6 million), is expected to attract patients from other countries in the region where the treatment is not available, particularly Indonesia, reports Malaysia's Business Times. The Hospital Pantai group owns and manages five hospitals in Malaysia with a total of 1,100 beds. In a separate development, three hospitals in Malaysia's Ipoh state are to launch a telemedicine service next year. The service will initially focus on nephrology, says the New Straits Times.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.